Long-term breast cancer response to CDK4/6 inhibition defined by TP53-mediated geroconversion is a research paper published in Cancer Cell (2024). On theSindex it has a DataRank of 0.416. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: R01CA234361
National Institutes of Health
Grant: R01CA245069
National Cancer Institute
Grant: P30CA008748
Susan G. Komen
Breast Cancer Research Foundation
Japan Society for the Promotion of Science
FWCI
3.92
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals